This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Dynport Vaccine Company LLC, Health Protection Agency. Active years: 2008-2013.
Company Filing History:
4 out of 4 
4 out of 38 
Years Active: 2008-2013
Title: The Innovations of Philip Vincent
Introduction
Philip Vincent is a notable inventor based in Salisbury, GB. He has made significant contributions to the field of biotechnology, particularly in the development of protective antigens. With a total of 4 patents to his name, Vincent's work has had a considerable impact on vaccine development and public health.
Latest Patents
Vincent's latest patents focus on the preparation of protective antigens. One of his key inventions involves a polynucleotide sequence that encodes recombinant Protective Antigen (rPA). This innovation includes expression vectors and host cells that utilize the polynucleotide sequence, along with methods for producing rPA. His work in this area is crucial for advancing vaccine technology.
Career Highlights
Throughout his career, Vincent has worked with several prominent organizations. Notably, he has been associated with Dynport Vaccine Company and the Health Protection Agency. His experience in these companies has allowed him to apply his innovative ideas in practical settings, contributing to advancements in vaccine research and development.
Collaborations
Vincent has collaborated with various professionals in his field. Some of his notable coworkers include Ian McEntee and Nigel Allison. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Philip Vincent's contributions to the field of biotechnology, particularly in the area of protective antigens, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing public health through innovative solutions.